Feredj, E. http://orcid.org/0000-0001-8301-0850
Wiedemann, A.
Krief, C.
Maitre, B.
Derumeaux, G.
Chouaid, C.
Le Corvoisier, P.
Lacabaratz, C.
Gallien, S.
Lelièvre, J. D.
Boyer, L.
Article History
Received: 4 November 2022
Accepted: 6 July 2023
First Online: 19 July 2023
Competing interests:
: C.C has consultant arrangements and has received grants from Astra Zeneca, Boehringer Ingelheim, MSD, Pierre Fabre Oncology, Lilly, Roche, Bristol Myers Squibb, and Novartis. J.D.L has board membership with IVIR-AC Comitee WHO, Member of the French NITAG, Work package leader VRI (HIV vaccine-France), Work package leader EHVA project (HIV vaccine-EU), Work package leader Vaccelerate project (COVID19 vaccine-EU). The rest of the authors declare that they have no relevant conflicts of interest.